UKAS
Mary Alikian is a Principal Clinical Scientist at C&S GLH since June 2020 and holds dual roles at Imperial College London as a Visiting Lecturer and Honorary Research Associate focused on molecular quantification in haematological malignancies and personalized medicine. In addition to being a UKAS Technical Assessor for ISO15189:2012 since April 2019, Mary has experience as a Senior Program Manager at The Institute of Cancer Research. Previously, as a Senior Clinical Scientist at Imperial College Healthcare NHS Trust, Mary led the establishment of a genomics lab within the 100K genomes project. Academic credentials include a Ph.D. in Molecular Pathology and Genomic Medicine from Imperial College London and an upcoming Executive MBA from Quantic School of Business and Technology.
This person is not in any teams
This person is not in any offices